Replies to post #24457 on CytoSorbents Corporation (CTSO)

[hemopure36]

I agree that Q3 will probably not be blockbuster, but as you know, at this point, I don't think quarterly revenues are what drives value for me. What drives value are upcoming catalysts, of which there are many, but I don't need to go through all those here. I too am frustrated at the pace and share price, but really believe that the offering will prove to be a necessary stabilizing measure that serves to accelerate our growth and approvals much faster than otherwise. That was a very significant de-risking event. We are well capitalized to accelerate our business with multiple approvals and the subsequent need to ramp up production, which in my opinion, is just around the corner.